CDH2 and neoplasm: This process increased the aggressiveness of the tumor by the loss of the epithelial phenotype (E-cadherin, desmosin, laminin-1) and the acquisition of the mesenchymal marker (N-cadherin) (Kalluri & Robert, 2009).